LOGO 135
Generic Name: fenofibric acid
Pill imprint LOGO 135 has been identified as Trilipix 135 mg.
Trilipix is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy.
Trilipix 135 mg is not subject to the Controlled Substances Act.
See also related documents.
Trilipix Images
- Generic Name:
- fenofibric acid
- Imprint:
-
LOGO
135 - Strength:
- 135 mg
- Color:
- Blue & Yellow
- Size:
- 22.00 mm
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
povidone
water
hydroxypropyl cellulose
silicon dioxide
sodium stearyl fumarate
magnesium silicate
triethyl citrate
gelatin
titanium dioxide
FD&C Blue No. 2
ferric oxide yellow
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-9189
| NDC Code | Manufacturer / Repackager |
|---|---|
| 23490-0033 | Palmetto State Pharmaceuticals Inc (repackager) |
| 54868-5986 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Trilipix resources
- Trilipix
- Trilipix Delayed-Release Capsules (Wolters Kluwer)
- Trilipix (Cerner Multum)
- Trilipix (Micromedex) - Includes Dosage Information
- Trilipix (FDA)
Search Again
